No Data
No Data
IRhythm Technologies Says Zio LTCM Shows 'Highest Diagnostic Yield' Vs Other Devices
IRhythm Presents AVALON Study Results at HRS2025, Showcasing Largest Real-World ACM Analysis
IRhythm Technologies Presents AVALON Study Findings Demonstrating Superiority of Zio LTCM in Commercially Insured Patients at HRS2025
Earnings Preview: IRTC to Report Financial Results Post-market on May 01
The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, IRhythm Technologies and SOPHiA GENETICS
Investors in IRhythm Technologies (NASDAQ:IRTC) Have Unfortunately Lost 23% Over the Last Three Years